NOX1 and neoplasm: In order to further investigate the role of NOX1 and its potential as a therapeutic target in the treatment of HCC, we studied the effect of the NOX1 inhibitor GKT771 (provided by Genkyotex) in a DEN-induced HCC mouse model, with specific focus on the inflammatory tumor microenvironment (TME).